Group One Trading’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-100
| Closed | -$965 | – | 8999 |
|
|
2025
Q3 | $965 | Sell |
100
-5,400
| -98% | -$47.8K | ﹤0.01% | 8062 |
|
|
2025
Q2 | $45.2K | Sell |
5,500
-1,100
| -17% | -$9.21K | ﹤0.01% | 5659 |
|
|
2025
Q1 | $47.2K | Buy |
6,600
+1,600
| +32% | +$11.9K | ﹤0.01% | 5214 |
|
|
2024
Q4 | $38.6K | Buy |
5,000
+3,600
| +257% | +$33.8K | ﹤0.01% | 5252 |
|
|
2024
Q3 | $14.7K | Sell |
1,400
-500
| -26% | -$6.09K | ﹤0.01% | 5401 |
|
|
2024
Q2 | $22.2K | Sell |
1,900
-1,300
| -41% | -$20.2K | ﹤0.01% | 5148 |
|
|
2024
Q1 | $67.4K | Buy |
3,200
+2,000
| +167% | +$35.6K | ﹤0.01% | 4458 |
|
|
2023
Q4 | $21.5K | Buy |
1,200
+1,100
| +1,100% | +$19.4K | ﹤0.01% | 5693 |
|
|
2023
Q3 | $1.65K | Sell |
100
-4,000
| -98% | -$72.5K | ﹤0.01% | 7099 |
|
|
2023
Q2 | $82K | Buy |
+4,100
| New | +$79K | ﹤0.01% | 4810 |
|
|
2023
Q1 | – | Sell |
-3,000
| Closed | -$68K | – | 7834 |
|
|
2022
Q4 | $68K | Sell |
3,000
-9,900
| -77% | -$224K | ﹤0.01% | 4772 |
|
|
2022
Q3 | $341K | Buy |
12,900
+7,400
| +135% | +$220K | ﹤0.01% | 3616 |
|
|
2022
Q2 | $136K | Sell |
5,500
-13,400
| -71% | -$335K | ﹤0.01% | 4684 |
|
|
2022
Q1 | $627K | Buy |
18,900
+12,500
| +195% | +$347K | ﹤0.01% | 3571 |
|
|
2021
Q4 | $209K | Sell |
6,400
-121,900
| -95% | -$4.15M | ﹤0.01% | 5046 |
|
|
2021
Q3 | $5.38M | Buy |
128,300
+126,900
| +9,064% | +$4.57M | 0.01% | 1609 |
|
|
2021
Q2 | $54K | Sell |
1,400
-5,300
| -79% | -$190K | ﹤0.01% | 6515 |
|
|
2021
Q1 | $229K | Buy |
+6,700
| New | +$286K | ﹤0.01% | 4888 |
|
|
2020
Q3 | – | Sell |
-6,400
| Closed | -$236K | – | 6483 |
|
|
2020
Q2 | $236K | Sell |
6,400
-22,600
| -78% | -$843K | ﹤0.01% | 3251 |
|
|
2020
Q1 | $939K | Buy |
29,000
+1,900
| +7% | +$79.2K | 0.01% | 1570 |
|
|
2019
Q4 | $1.11M | Buy |
27,100
+26,000
| +2,364% | +$1.03M | 0.01% | 1787 |
|
|
2019
Q3 | $39K | Sell |
1,100
-51,700
| -98% | -$2.09M | ﹤0.01% | 4093 |
|
|
2019
Q2 | $2.71M | Buy |
52,800
+12,100
| +30% | +$604K | 0.02% | 874 |
|
|
2019
Q1 | $2.33M | Sell |
40,700
-19,200
| -32% | -$951K | 0.03% | 837 |
|
|
2018
Q4 | $2.51M | Buy |
59,900
+57,900
| +2,895% | +$3.4M | 0.02% | 878 |
|
|
2018
Q3 | $151K | Sell |
2,000
-3,200
| -62% | -$231K | ﹤0.01% | 3216 |
|
|
2018
Q2 | $373K | Sell |
5,200
-200
| -4% | -$9.55K | ﹤0.01% | 2547 |
|
|
2018
Q1 | $161K | Buy |
+5,400
| New | +$157K | ﹤0.01% | 2932 |
|
Other funds holding RGNX
RG
VCM
IHAM
Group One Trading's RGNX Position: Q1 2026 in Review
Group One Trading increased its Regenxbio (RGNX) stake by 109% in Q1 2026, buying an estimated $9.18K and bringing the position to 1,678 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6163.
Group One Trading first reported a position in RGNX in Q4 2017 and has held it in 22 quarters since. The position peaked at $2.06M in Q2 2019. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Group One Trading held 1,678 shares of Regenxbio worth $14.1K as of Q1 2026.
- Group One Trading bought 874 Regenxbio shares in Q1 2026, an estimated $9.18K.
- Regenxbio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6163 holding.
- Group One Trading first reported a position in Regenxbio in Q4 2017 and has held it in 22 quarters since.
- Group One Trading's Regenxbio position peaked at $2.06M in Q2 2019.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.